Practice

Commentary: Condition is often overlooked

BMJ 2009; 338 doi: 10.1136/bmj.b799 (Published 9 March 2009)
Cite this as: BMJ 2009;338:b799

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Gerhard J Molderings, associate professor of pharmacology and toxicology
  1. 1Institute of Human Genetics, University Hospital of Bonn, D-53111 Bonn, Germany
  1. molderings{at}uni-bonn.de

    This report of hypotensive shock as the initial sign of systemic mastocytosis brings attention to an important but underestimated disease. Although systemic mast cell activation syndrome, a variant form of systemic mastocytosis, is probably common in daily practice (for example, it seems to be linked to certain forms of irritable bowel syndrome1), this differential diagnosis is seldom considered. As in the …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular